Bone Marrow Transplantation

Top Story

ASH announces award recipients

July 15, 2019

City of Hope appoints hematologists to new roles

July 3, 2019
Two hematologists at City of Hope have been appointed to new positions. Larry Kwak, MD, PhD, has been named deputy director of City of Hope’s Hematologic…
Pharmacology Consult

The good, bad and unnecessary prescribing of oral vancomycin prophylaxis in immunosuppressed patients

Infectious Disease News, June 2019
Jennifer Ross, PharmD; Kimberly D. Boeser, PharmD, MPH, BCIDP
Clostridioides difficile infection, or CDI, continues to be a significant pathogen in both hospitals and community-based settings. The associated morbidity, mortality…
In the JournalsPerspective

European guidelines recommend letermovir as CMV prophylaxis in HSCT recipients

June 12, 2019
Updated clinical practice guidelines prepared by the European Conference on Infections in Leukemia recommend the use of letermovir for the prevention of cytomegalovirus…
More Headlines »

2019 Texas Oncology Clinical Educational Symposium

This activity is supported by educational grants from AbbVie, Inc.; Celgene Corporation; Novartis Pharmaceuticals Corporation; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.; Takeda Oncology; and Verastem, Inc..

Clinical outcomes for advanced cancers continue to improve through the identification as well as the development of…
More »

Baseball Hall of Famer Mike Schmidt ‘paying it forward’ through campaign to support patients with cancer

September 21, 2017
More »

Risky Business: Prophylaxis and Treatment of Cytomegalovirus in the Transplantation Setting

This activity is supported by educational grants from Merck & Co., Inc. and Shire.

Cytomegalovirus (CMV) is a common herpes virus that affects 50% to 80% of the US population. Disease from reactivation…
More »